Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored

Publisher： John Wiley & Sons Inc

E-ISSN： 1521-4036|57|3|371-383

ISSN： 0323-3847

Source： BIOMETRICAL JOURNAL, Vol.57, Iss.3, 2015-05, pp. : 371-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methods for exploring treatment effect heterogeneity in subgroup analysis: an application to global clinical trials

By  

PHARMACEUTICAL STATISTICS: THE JOURNAL OF APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY, Vol. 14, Iss. 1, 2015-01 ,pp. : 44-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing potentially time‐dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 11, 2015-05 ,pp. : 1801-1817

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modeling clustering and treatment effect heterogeneity in parallel and stepped‐wedge cluster randomized trials

By  

STATISTICS IN MEDICINE, Vol. 37, Iss. 6, 2018-03 ,pp. : 883-898

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intention‐to‐treat analysis with treatment discontinuation and missing data in clinical trials

By  

STATISTICS IN MEDICINE, Vol. 34, Iss. 16, 2015-07 ,pp. : 2381-2390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe?

By  

CLINICAL LIVER DISEASE (ELECTRONIC), Vol. 6, Iss. 5, 2015-11 ,pp. : 120-121

John Wiley & Sons Inc

Access to resources Recommend Favorite